Cellebrite DI Ltd. $CLBT Stake Lessened by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D cut its stake in Cellebrite DI Ltd. (NASDAQ:CLBT) by 33.1% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 55,588 shares of the company’s stock after selling 27,447 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Cellebrite DI were worth $889,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CLBT. Wealth Enhancement Advisory Services LLC bought a new position in Cellebrite DI during the 1st quarter valued at $269,000. Teacher Retirement System of Texas boosted its stake in Cellebrite DI by 121.3% during the first quarter. Teacher Retirement System of Texas now owns 44,407 shares of the company’s stock valued at $863,000 after buying an additional 24,337 shares in the last quarter. OneDigital Investment Advisors LLC boosted its stake in Cellebrite DI by 2.5% during the first quarter. OneDigital Investment Advisors LLC now owns 28,591 shares of the company’s stock valued at $556,000 after buying an additional 688 shares in the last quarter. Catalyst Capital Advisors LLC bought a new position in shares of Cellebrite DI during the 1st quarter valued at about $51,000. Finally, Bank of New York Mellon Corp bought a new position in shares of Cellebrite DI during the 1st quarter valued at about $22,428,000. 45.88% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CLBT shares. JPMorgan Chase & Co. raised their price objective on shares of Cellebrite DI from $20.00 to $23.00 and gave the company an “overweight” rating in a research report on Wednesday, September 24th. Weiss Ratings restated a “sell (d+)” rating on shares of Cellebrite DI in a report on Wednesday, October 8th. Wall Street Zen upgraded shares of Cellebrite DI from a “hold” rating to a “buy” rating in a report on Friday, September 26th. Lake Street Capital reduced their price objective on Cellebrite DI from $24.00 to $22.00 and set a “buy” rating for the company in a research note on Friday, August 15th. Finally, Needham & Company LLC reduced their price objective on Cellebrite DI from $24.00 to $18.00 and set a “buy” rating for the company in a research note on Thursday, August 14th. Four research analysts have rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Cellebrite DI presently has an average rating of “Moderate Buy” and a consensus price target of $21.75.

Cellebrite DI Price Performance

Shares of CLBT opened at $17.06 on Monday. The company has a 50-day moving average of $17.80 and a two-hundred day moving average of $16.85. Cellebrite DI Ltd. has a one year low of $13.10 and a one year high of $26.30. The stock has a market cap of $4.09 billion, a price-to-earnings ratio of -22.45, a PEG ratio of 3.16 and a beta of 1.29.

Cellebrite DI (NASDAQ:CLBT) last posted its quarterly earnings data on Thursday, August 14th. The company reported $0.12 EPS for the quarter, topping analysts’ consensus estimates of $0.11 by $0.01. Cellebrite DI had a negative net margin of 34.56% and a positive return on equity of 23.92%. The firm had revenue of $113.28 million during the quarter, compared to analyst estimates of $112.33 million. During the same quarter last year, the business posted $0.10 EPS. The company’s revenue was up 18.4% on a year-over-year basis. Cellebrite DI has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. Analysts anticipate that Cellebrite DI Ltd. will post 0.3 earnings per share for the current year.

About Cellebrite DI

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.